0
ARTICLE |

DANGER OF THE ADMINISTRATION OF EPHEDRINE IN HEART FAILURE

W. A. BLOEDORN, M.D.; P. F. DICKENS, M.D.
Arch Intern Med (Chic). 1928;42(3):322-330. doi:10.1001/archinte.1928.00020020010002.
Text Size: A A A
Published online

ABSTRACT

While ephedrine has been employed in Chinese medicine for over five thousand years, it has been only in the past five years, since its reisolation and careful study by Chen and Schmidt, that modern medicine has added it to the list of drugs in daily use. In 1923, Chen called attention to ephedrine and conducted a careful study of its physiologic effect, so that in a short time the drug became popularized and freely used by practitioners of medicine and even by laymen.

At the present time, the drug is widely used for a variety of conditions, and the literature contains many interesting and instructive articles regarding its pharmacology, mode of action and therapeutic uses.

From time to time attention has been called to certain untoward effects from the use of this drug, and it is not considered amiss at this time to emphasize the point that this drug is

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Correspondence

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 1

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs